SHAB published 1 Feb 2022 · legal date 18 Jan 2022
Capital increase
Not assessed
Paid in cash
Nominal capital
135’761 → 160’536
Shares
135’761 → 160’536
New shares, % of post-step shares
15.4% (24’775 new)
Aktienkapital neu: CHF 160'536.00 [bisher: CHF 135'761.00]. Liberierung Aktienkapital neu: CHF 160'536.00 [bisher: CHF 135'761.00]. Aktien neu: 160'536 Namenaktien zu CHF 1.00 [bisher: 135'761 Namenaktien zu CHF 1.00]. Die Gesellschaft hat mit Beschluss vom 18.01.2022 eine genehmigte Kapitalerhöhung gemäss näherer Umschreibung in den Statuten beschlossen.
SHAB published 7 Aug 2025 · legal date 26 Jun 2025
Capital increase
●●○Likely financing
Paid in cash and by other means
Nominal capital
166’482 → 189’352.50
Shares
166’482 → 18’935’250
New shares, % of post-step shares
— (nominal value per share changed)
Aktienkapital neu: CHF 189'352.50 [bisher: CHF 166'482.00]. Liberierung Aktienkapital neu: CHF 189'352.50 [bisher: CHF 166'482.00]. Aktien neu: 18'935'250 Namenaktien zu CHF 0.01 [bisher: 166'482 Namenaktien zu CHF 1.00]. [gestrichen: Die Gesellschaft hat mit Beschluss vom 18.01.2022 eine genehmigte Kapitalerhöhung gemäss näherer Umschreibung in den Statuten beschlossen.].
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company was founded less than six years before this capital increase.+0.5
The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.72 · likely-financing threshold 0.60 · not a calibrated probability